Sign In
Buy FENC
$9.14
-0.84 (-8.42%)
At Close: Jun 03, 2026
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
07:01am, Thursday, 12'th Dec 2024
RESEARCH TRIANGLE PARK, N.C., Dec. 12, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Compa
Fennec Pharmaceuticals to Participate in Upcoming Investor Conference
06:27am, Wednesday, 13'th Nov 2024
RESEARCH TRIANGLE PARK, N.C., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Compa
Fennec Pharmaceuticals Inc. (FENC) Q3 2024 Earnings Call Transcript
10:33pm, Saturday, 09'th Nov 2024
Fennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q3 2024 Earnings Conference Call November 9, 2024 8:30 AM ET Company Participants Robert Andrade - Chief Financial Officer Jeff Hackman - Chief Executive Off
Adherex Technologies Inc. (FENC) Reports Q3 Loss, Misses Revenue Estimates
08:26am, Thursday, 07'th Nov 2024
Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.21 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to loss of $0.07 per share a year ago.
Fennec Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
06:13am, Thursday, 07'th Nov 2024
~ Achieved Third Quarter 2024 Net Product Sales of $7.0 Million ~ ~ Increasing Momentum and Successful Reimbursement in the Adolescent and Young Adult (AYA) Segment Following Strategic Investments to
Fennec Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024
06:23am, Thursday, 31'st Oct 2024
RESEARCH TRIANGLE PARK, N.C., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Comp
Analysts Estimate Adherex Technologies Inc. (FENC) to Report a Decline in Earnings: What to Look Out for
11:05am, Monday, 28'th Oct 2024
Adherex Technologies (FENC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
~ Pierre S. Sayad, PhD, M.S.
Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences
06:56am, Thursday, 05'th Sep 2024
RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a commercial stage specialty pharmaceutical company, today announced that the Comp
Fennec Pharmaceuticals Inc. (FENC) Q2 2024 Earnings Call Transcript
02:20pm, Tuesday, 13'th Aug 2024
Fennec Pharmaceuticals Inc. (NASDAQ:FENC ) Q2 2024 Earnings Conference Call August 13, 2024 8:30 AM ET Company Participants Robert Andrade - CFO Jeffrey Hackman - CEO and Board Member Conference Call
Adherex Technologies Inc. (FENC) Reports Q2 Loss, Lags Revenue Estimates
08:26am, Tuesday, 13'th Aug 2024
Adherex Technologies Inc. (FENC) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of $0.06. This compares to loss of $0.21 per share a year ago.
Fennec Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
06:05am, Tuesday, 13'th Aug 2024
~ Achieved Second Quarter 2024 Total Net Revenues of $7.3 Million ~ ~ Appointed Jeffrey S. Hackman as Chief Executive Officer (CEO) and Member of the Board of Directors ~ ~ Company Has Approximately $
Fennec Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 13, 2024
04:31pm, Tuesday, 06'th Aug 2024
Company to Also Participate in 2024 Wedbush PacGrow Healthcare Conference Company to Also Participate in 2024 Wedbush PacGrow Healthcare Conference
Fennec Pharmaceuticals Appoints Jeffrey S. Hackman as Chief Executive Officer and Director
06:26am, Monday, 05'th Aug 2024
~ Accomplished Industry Leader Brings Extensive Commercialization and Oncology Expertise ~ ~ Assumes Leadership Role at Critical Time to Expand Use of PEDMARK®, the First and Only Approved Treatment
3 Dirt-Cheap Stocks Under $10 That Could EXPLODE!
06:15am, Monday, 29'th Jul 2024
Investing in dirt cheap stocks under $10 has a lot of appeal. One of the benefits is that a low share price allows you to buy more shares with a smaller amount of money.
